These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21635955)

  • 1. Population-wide principal component-based quantification of blood-brain-barrier dynamics in multiple sclerosis.
    Shinohara RT; Crainiceanu CM; Caffo BS; Gaitán MI; Reich DS
    Neuroimage; 2011 Aug; 57(4):1430-46. PubMed ID: 21635955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions.
    Gaitán MI; Shea CD; Evangelou IE; Stone RD; Fenton KM; Bielekova B; Massacesi L; Reich DS
    Ann Neurol; 2011 Jul; 70(1):22-9. PubMed ID: 21710622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE ΔT1 mapping.
    Choi S; Spini M; Hua J; Harrison DM
    PLoS One; 2021; 16(4):e0249973. PubMed ID: 33901207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement.
    Kermode AG; Tofts PS; Thompson AJ; MacManus DG; Rudge P; Kendall BE; Kingsley DP; Moseley IF; du Boulay EP; McDonald WI
    Neurology; 1990 Feb; 40(2):229-35. PubMed ID: 2300240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis.
    Jurcoane A; Wagner M; Schmidt C; Mayer C; Gracien RM; Hirschmann M; Deichmann R; Volz S; Ziemann U; Hattingen E
    J Magn Reson Imaging; 2013 Dec; 38(6):1454-61. PubMed ID: 23554005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T.
    Ingrisch M; Sourbron S; Morhard D; Ertl-Wagner B; Kümpfel T; Hohlfeld R; Reiser M; Glaser C
    Invest Radiol; 2012 Apr; 47(4):252-8. PubMed ID: 22373532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relating multi-sequence longitudinal intensity profiles and clinical covariates in incident multiple sclerosis lesions.
    Sweeney EM; Shinohara RT; Dewey BE; Schindler MK; Muschelli J; Reich DS; Crainiceanu CM; Eloyan A
    Neuroimage Clin; 2016; 10():1-17. PubMed ID: 26693397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI evidence of acute inflammation in leukocortical lesions of patients with early multiple sclerosis.
    Maranzano J; Rudko DA; Nakamura K; Cook S; Cadavid D; Wolansky L; Arnold DL; Narayanan S
    Neurology; 2017 Aug; 89(7):714-721. PubMed ID: 28724581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative MRI for Analysis of Active Multiple Sclerosis Lesions without Gadolinium-Based Contrast Agent.
    Blystad I; Håkansson I; Tisell A; Ernerudh J; Smedby Ö; Lundberg P; Larsson EM
    AJNR Am J Neuroradiol; 2016 Jan; 37(1):94-100. PubMed ID: 26471751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial investigation of the blood-brain barrier in MS lesions at 7 tesla.
    Gaitán MI; Sati P; Inati SJ; Reich DS
    Mult Scler; 2013 Jul; 19(8):1068-73. PubMed ID: 23246799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement.
    Vellinga MM; Oude Engberink RD; Seewann A; Pouwels PJ; Wattjes MP; van der Pol SM; Pering C; Polman CH; de Vries HE; Geurts JJ; Barkhof F
    Brain; 2008 Mar; 131(Pt 3):800-7. PubMed ID: 18245785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automatic detection of gadolinium-enhancing multiple sclerosis lesions in brain MRI using conditional random fields.
    Karimaghaloo Z; Shah M; Francis SJ; Arnold DL; Collins DL; Arbel T
    IEEE Trans Med Imaging; 2012 Jun; 31(6):1181-94. PubMed ID: 22318484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals.
    Cotton F; Weiner HL; Jolesz FA; Guttmann CR
    Neurology; 2003 Feb; 60(4):640-6. PubMed ID: 12601106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.
    Kappos L; Moeri D; Radue EW; Schoetzau A; Schweikert K; Barkhof F; Miller D; Guttmann CR; Weiner HL; Gasperini C; Filippi M
    Lancet; 1999 Mar; 353(9157):964-9. PubMed ID: 10459905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions.
    Absinta M; Sati P; Schindler M; Leibovitch EC; Ohayon J; Wu T; Meani A; Filippi M; Jacobson S; Cortese IC; Reich DS
    J Clin Invest; 2016 Jul; 126(7):2597-609. PubMed ID: 27270171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis.
    Miller DH; Rudge P; Johnson G; Kendall BE; Macmanus DG; Moseley IF; Barnes D; McDonald WI
    Brain; 1988 Aug; 111 ( Pt 4)():927-39. PubMed ID: 3401689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing brain MRI protocols in the follow-up of patients with multiple sclerosis T2-weighted MRI of the brain after the administration of gadopentetate dimeglumine.
    Taschner CA; Kirsch EC; Scheffler K; Wetzel SG; Schulte-Mönting J; Kappos L; Radü EW
    Magn Reson Imaging; 2005 Apr; 23(3):469-74. PubMed ID: 15862648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seven-tesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory process.
    Absinta M; Sati P; Gaitán MI; Maggi P; Cortese IC; Filippi M; Reich DS
    Ann Neurol; 2013 Nov; 74(5):669-78. PubMed ID: 23813441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative T1 mapping detects blood-brain barrier breakdown in apparently non-enhancing multiple sclerosis lesions.
    Donatelli G; Cecchi P; Migaleddu G; Cencini M; Frumento P; D'Amelio C; Peretti L; Buonincontri G; Pasquali L; Tosetti M; Cosottini M; Costagli M
    Neuroimage Clin; 2023; 40():103509. PubMed ID: 37717382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hierarchical conditional random fields for detection of gad-enhancing lesions in multiple sclerosis.
    Karimaghaloo Z; Arnold DL; Collins DL; Arbel T
    Med Image Comput Comput Assist Interv; 2012; 15(Pt 2):379-86. PubMed ID: 23286071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.